LIN-15A Inhibitors
Chemical inhibitors of LIN-15A can affect the protein's function in multiple cellular signaling pathways. LY294002 and Wortmannin are both inhibitors of PI3K, a key component of the PI3K/Akt pathway, which is important for the regulation of cell proliferation and differentiation. Inhibition of PI3K by these chemicals would prevent the activation of Akt, and consequently, downstream targets that are necessary for LIN-15A's role in these processes may be affected. Rapamycin, by selectively inhibiting mTOR, another downstream effector of the PI3K/Akt pathway, can further disrupt the signaling required for LIN-15A's involvement in cell growth and proliferation.
Furthermore, the MEK inhibitors U0126, PD98059, and the more potent PD0325901, target the MAPK/ERK pathway, which is involved in cell cycle progression. Inhibition of MEK1/2 by these substances would suppress the activation of ERK, a vital part of the signaling cascade that LIN-15A may regulate. SB203580 and SP600125 specifically inhibit the p38 MAPK and JNK MAP kinases, respectively. The p38 MAPK pathway is associated with cellular stress responses, and JNK is involved in stress response and apoptosis. Inhibition of these kinases by SB203580 and SP600125 would limit the signaling required for LIN-15A to exert its effects in these contexts. Additionally, Y-27632's inhibition of ROCK, which is implicated in actin cytoskeleton organization, can impair processes that require cytoskeletal reorganization where LIN-15A is involved. Src family kinase inhibitors such as Dasatinib, PP2, and AZD0530, by inhibiting these kinases, can affect LIN-15A's role in signal transduction pathways linked to cell structure, organization, and survival.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
Inhibits the PI3K/Akt pathway, which LIN-15A may utilize for its function in the regulation of cell proliferation and differentiation. By inhibiting PI3K, LY294002 prevents the activation of downstream targets that could be necessary for LIN-15A's role in these processes. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
Inhibits MEK1/2, key enzymes in the MAPK/ERK pathway. LIN-15A is involved in regulating cell cycle progression, and the MAPK/ERK pathway is crucial for this process. Inhibition of MEK1/2 by U0126 would suppress the pathway's function, potentially hindering LIN-15A's associated activities. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
Inhibits p38 MAPK, which may intersect with pathways where LIN-15A functions, particularly in the context of cellular stress responses. Inhibition of p38 MAPK could therefore impede the signaling required for LIN-15A to exert its effects. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
Targets JNK, another MAP kinase involved in stress response and apoptosis. As LIN-15A could be implicated in similar cellular responses, inhibition of JNK by SP600125 might impair LIN-15A's functional contributions to these pathways. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Similar to LY294002, Wortmannin is a potent PI3K inhibitor. By suppressing PI3K, it would limit the activity of downstream signaling that may be critical for LIN-15A's role in cellular growth and survival processes. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Inhibits mTOR, a downstream effector of the PI3K/Akt pathway. mTOR is involved in cell growth and proliferation, processes potentially regulated by LIN-15A. By inhibiting mTOR, Rapamycin could disrupt functions where LIN-15A is involved. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
Inhibits MEK, which is upstream of ERK in the MAPK pathway. By inhibiting MEK, PD98059 would suppress ERK activation, potentially affecting LIN-15A's role in the regulation of cell proliferation and differentiation. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
Inhibits ROCK, a kinase implicated in actin cytoskeleton organization. Since LIN-15A may be involved in processes that require cytoskeletal reorganization, inhibition of ROCK by Y-27632 could impair LIN-15A's associated functions. | ||||||
Dasatinib | 302962-49-8 | sc-358114 sc-358114A | 25 mg 1 g | $70.00 $145.00 | 51 | |
A Src family kinase inhibitor which could impact signaling pathways involving cell structure and organization, areas where LIN-15A might be active. By inhibiting these kinases, Dasatinib may interfere with LIN-15A's functional role. | ||||||
PP 2 | 172889-27-9 | sc-202769 sc-202769A | 1 mg 5 mg | $94.00 $227.00 | 30 | |
Another Src family kinase inhibitor, PP2, could disrupt signaling cascades that LIN-15A is part of, especially those related to cell adhesion and migration, by preventing Src kinase activity. | ||||||